2026 - Hadean Ventures

Complement Therapeutics : First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study

by @hadeanventures on March 25, 2026

Complement Therapeutics : First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study —…
Continue Reading
First patient dosed in Gesynta Pharma’s endometriosis trial of vipoglanstat

by @hadeanventures on March 11, 2026

First patient dosed in Gesynta Pharma’s endometriosis trial of vipoglanstat — Hadean Ventures Home Portfolio…
Continue Reading

What are you looking for?